Advanced Tumor Bank Project
- To provide a tissue and cell repository to be used by Wake Forest University
Comprehensive Cancer Center (WFUCCC) investigators.
- To provide specialized research pathology services to these investigators.
OUTLINE: Tumor and normal tissue in the resected specimen (when possible) are harvested and
collected from patients undergoing planned surgery or biopsy. Additionally, any normal
tissue and/or fluid removed in the course of the operation (e.g., cerebrospinal fluid during
brain tumor resection) may also be stored for use in analyzing changes from normal tissue to
cancerous tissue. Specimens are rapidly frozen in liquid nitrogen to preserve the mRNA,
proteins, lipids, and DNA in the samples for future analysis. Tissue is stored for research
projects on tumors and treatment of cancer patients. Research may involve analysis of the
genetic makeup of the tumor tissue. Genes may be cloned and living cells cultured from the
stored tissue. Blood is also collected during surgery. Samples are maintained and cataloged
for future retrieval.
Information about medical history is collected from patient medical records. This
information includes the following: medical diagnosis; specific information about treatment;
other medical conditions; medical data (i.e., laboratory test results, tumor measurements,
CT scans, MRI scans, x-rays, and pathology results); side effects experienced and treatment
for side effects; long-term information about general health status and the status of
disease; data that may be related to tissue and/or blood samples collected; and identifying
numbers or codes (i.e., social security number and medical record number).
Observational Model: Case-Only
Tissue and cell repository for Wake Forest University Comprehensive Cancer Center investigators
Edward A. Levine, MD
Comprehensive Cancer Center of Wake Forest University
United States: Institutional Review Board
|Wake Forest University Comprehensive Cancer Center||Winston-Salem, North Carolina 27157-1096|